This was the day that could have been. Earnings were coming out favorably, yet the data just couldn't support the stocks. There were also trader comments that BofA/Merrill had large sell orders or sell programs throughout the day. It looks like the DJIA even closed out under the 10,000 mark on an unofficial basis.

Here were today's unofficial closing bell levels:

Dow 9,974.75 -106.56 (-1.06%)
S&P 500 1,079.73 -13.18 (-1.21%)
Nasdaq 2,154.47 -10.82 (-0.50%)

Top 10 Analyst Calls
Top Day Traders Stocks
Top Stock/Market Rumors

The earnings crunch ramps up this week, and again expectations are generally low. Among the so-called bellwethers that are expected to report lower earnings year over year are CSX Corp. (NYSE: CSX), Gannett Inc. (NYSE: GCI), General Electric Co. (NYSE: GE), Harley Davidson Inc. (NYSE: HOG), Intel Corp. (NASDAQ: INTC), International Business Machines Corp. (NYSE: IBM), Johnson & Johnson (NYSE: JNJ), Marriott International Inc. (NYSE: MAR), Mattel Inc. (NYSE: MAT), Nokia Corp. (NYSE: NOK), and Yum! Brands Inc. (NYSE: YUM). Analysts surveyed by Thomson Reuters do expect the profits of CSX, Gannett, Mattel, and Nokia to be up from the previous quarter, however.

A number of financial companies, big and small, are scheduled to report second-quarter earnings this week, providing a good look at what's going on in the sector. Perhaps the best news will be coming from Citigroup and Marshall & Ilsley. While they are expected to post further losses, at least they are headed in the right direction by narrowing those losses year over year.

"Midyear is as good a time as any to pause and reflect," says Richard Moroney in Dow Theory Forecasts -- a newsletter with the distinction of having been published for more than 50 years.

Here, he reviews the state of the market and offers a look at trio of favorite stocks which he considers "fundamentally superior" companies: Biogen Idec (NASDAQ: BIIB), Comcast (NASDAQ: CMCSA), and Oceaneering International (NYSE: OII).

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Anadarko Petroleum Corp. (NYSE: APC) reported that its Q4 profit tripled but it fell short of estimates.
• Biogen Idec Inc. (NASDAQ: BIIB) met earnings estimates but it is getting more pressure from Carl Icahn.
• BP (NYSE: BP) surprised Wall Street with a multibillion dollar Q4 loss due to lower oil prices.
• Cisco Systems Inc. (NASDAQ: CSCO) beat Q2 estimates but warned that incoming orders have declined.
• Dick's Sporting Goods Inc. (NYSE: DKS) reaffirmed its previous Q4 guidance, which pleased investors.
• Estee Lauder Companies Inc. (NYSE: EL) topped Q2 earings estimates and it announced job cuts.
• Humana Inc. (NYSE: HUM) Q4 earnings fell on higher claim expenses and lower investment income.
• JDS Uniphase Corp. (NASDAQ: JDSU) adjusted earnings were in line with estimates but revenue fell.

Today's rally came on strong as horrible unemployment data showed the need for a much stronger stimulus package. Expect a big package Monday, or at least expect a huge sell-off in many banks and financials if not. Here are the unofficial closing bell levels:


Dow 8,280.59 +217.52 (2.70%)
S&P 500 868.56 +22.71 (2.68%)
Nasdaq 1,591.71 +45.47 (2.94%)

When you have a trading day like today and it comes after a week like this week, it is hard to determine if you are happier that the rally came on at the end of the day or if you are happier that the closing bell came to end the week. The markets closed down today but today felt like a win when you consider the 400 point move higher off of late day lows in the last hour. There are hopes of a coordinated G7 announcement this week along with some fresh hopes that the Treasury will make new banking injections and help in the LIBOR woes. The bond traders left at 2:00 PM early for Columbus Day, and the bond market is closed Monday.

Here are the unofficial closing bell levels, and remember that the exchange takes much longer to find actual close levels right now:
DJIA 8,477.40 -101.79 -1.19%
NASDAQ 1,649.51 +4.39 +0.27%
S&P500 901.24 -8.68 -0.95%
10YR T-NOTE 3.861% +0.027%
Top Analyst Upgrades

Barclays plc (NYSE: BCS) fell on reports that the financial bank giant is considering raising capital as part of the government's bailout package in the UK. Shares were down 9% at $14.66 in the final minutes before the close.

Shares of Biogen Idec Inc. (NASDAQ: BIIB) plummeted on news that its multiple-sclerosis drug Tysabri was linked to brain infections causing death, leaving 4.3% shareholder Carl Icahn with a hefty paper loss.

But Icahn didn't back down. Having already pushed for one unsuccessful effort to sell the company, and having lost a bid for three seats on the board of directors, Icahn filed a 13-D announcing that he had raised his stake to 6.1%, buying in the wake of the brain infection announcement.

As one of the smarter activist value investors going, Carl Icahn's moves are closely watched by investors looking to piggyback off his ideas.

Biogen (NASDAQ: BIIB) was trading at $54.71 in pre-open trading, below its close of $69.76 Thursda. BIIB and Elan (NYSE: ELN) announced their multiple sclerosis treatment Tysabri, was linked to brain infection. BIIB August option implied volatility was at 42, September at 39; near its 26-week average of 39 according to Track Data, suggesting non-directional price movement.

ELN was trading at $10.78 in pre-open trading, below its close of $20.05. ELN August option implied volatility was at 65, October at 58; below its 26-week average of 70, suggesting decreasing price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

The Hershey Co. (NYSE: HSY) is recently up 98 cents to $37.49. HSY has a market cap of $8.4 billion with long term debt of $1.5 billion. HSY call option volume of 12,177 contracts compares to put volume of 1,008 contracts. HSY June option implied volatility of 37 is above its 26-week average of 27 according to Track Data, suggesting larger price movement.

Biogen's (NASDAQ: BIIB) recent volatility has collapsed after Carl Icahn proposed a slate of directors.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

The earnings crunch continues, and here are a few of the highlights of this past week's earnings coverage from BloggingStocks:

• Alcatel-Lucent (NYSE: ALU) posted its biggest quarterly loss since its creation in 2006.
• Archer Daniels Midland Co. (NYSE: ADM) missed earnings estimates despite revenue up 50%.
• Biogen Idec Inc. (NASDAQ: BIIB) fourth-quarter profit soared on strong sales of Avonex and Tysabri.
• Chevron Corp. (NYSE: CVX) reported record profits due to surging oil prices.
• CNET Networks Inc. (NASDAQ: CNET) revenue rose but the forecast was not encouraging.
• Data Domain Inc. (NASDAQ: DDUP) third-quarter revenues spiked due to aggressive overseas expansion.
• Elizabeth Arden Inc. (NASDAQ: RDEN) benefitted from overseas growth, which offset weak holiday sales.
• GlaxoSmithKline (NYSE: GSK) warned that 2008 earnings would be affected by competition from generics.
• Harris Corp. (NYSE: HRS) beat estimates and raised its guidance.
• Micros Systems (NASDAQ: MCRS) beat expectations and offered guidance in line with estimates.
• News Corp. (NYSE: NWS) fell short of earnings expectations despite strength in MySpace and Fox News.
• PepsiCo Inc. (NYSE: PEP) results met estimates and it announced further share buybacks.
• Polo Ralph Lauren Corp. (NYSE: RL) beat estimates and raised its guidance.
• SiRF Technology Holdings Inc. (NASDAQ: SIRF) missed expectations due to a seasonal decline.
• Toll Brothers Inc. (NYSE: TOL) expects to report its seventh straight quarterly revenue decline.
• Toyota Motor Corp. (NYSE: TM) attributed solid earnings to growth in China, Russia, emerging markets.
• Wendy's International Inc. (NYSE: WEN) missed earnings estimates, despite beating revenue forecast.
• Western Union Co. (NYSE: WU) posted results just ahead of Wall Street estimates.
• Yum! Brands (NYSE: YUM) posted solid results on overseas growth and share buybacks.

MAJOR PAPERS:

• Australian resources firm BHP Billiton Limited (NYSE: BHP) is unlikely to up its $99.22B bid to acquire mining company Rio Tinto PLC (NYSE: RTP), according to the Wall Street Journal.
• Ten years after taking the reins at eBay Inc (NASDAQ: EBAY), CEO Meg Whitman is making plans to retire, reported the Wall Street Journal. Company president John Donahoe is the leading candidate to replace her.
• According to the Financial Times, Biogen Idec Incorporated (NASDAQ: BIIB) CEO Jim Mullen said the company could make a "large-scale acquisition" this year after it failed to sell itself.

WEB SITES:

• Finance companies including Citigroup Incorporated (NYSE: C) could sell proprietary investments in India as they struggle to shore up their capital after suffering losses in the subprime sector in the U.S., LiveMint.com reported.

Monday, January 4

• Teleflex Incorporated (NYSE: TFX) to give preliminary business outlook at 9:00am.
• LifeCell Corporation (NASDAQ: LIFC) to give guidance at 10:00am.
• Atlanta Fed Reserve Bank President Lockhart to speak on the economy in Atlanta, GA at 12:40pm.
• Lawson Software, Inc. (NASDAQ: LWSN) to report Q2 earnings; conference call at 4:30pm

Tuesday, January 5

• Immucor Inc. (NASDAQ: BLUD) to report Q2 earnings; conference call at 8:30am.
• Constellation Brands, Inc. (NYSE: STZ) to report Q3 earnings; conference call at 10:00am.
• Eastman Kodak Company (NYSE: EK) conference call from the Consumer Electronics Show in Las Vegas at 12:00pm.
• Conceptus, Inc. (NASDAQ: CPTS) to give 2008 guidance at 4:30pm.
• PDUFA Date for Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) Evicel a Fibrin Sealant for Hemostasis (bleeding control) during kidney surgery.

Wednesday, January 6

• Navios Maritime Holdings Inc. (NYSE: NM) to discuss launch of their South American Logistics business at 8:30am.
• Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) to give guidance at 9:00am.
• Alcoa Inc. (NYSE: AA) to report Q4 earnings; conference call at 5:00pm.

Thursday, January 7

• The Gap Inc. (NYSE: GPS) and Wal-Mart Stores, Inc. (NYSE: WMT) to report monthly sales at 8:00am, Target Corporation (NYSE: TGT) to report monthly sales at 8:30am.
• Federal Reserve Bank of St Louis Bank President Hoenig to speak on economic outlook in St. Louis, Missouri at 1:00pm.

Friday, January 8

• PDUFA Date for Biogen Idec Inc. (NASDAQ: BIIB) and Elan Corporation, plc (ADR) (NYSE: ELN) Tysabri for treating moderately to severely active Crohn's Disease.

Biogen Idec Inc. (NASDAQ: BIIB) will continue on its present course as an independent company after BIIB's Board of Directors completed a review of strategic alternatives to maximize shareholder value:

BIIB recently traded at $56.60 in after market trading, below its close of $75.88. BIIB December straddle went out at $6.35. BIIB January option implied volatility of 55 is above its 26-week average of 37 according to Track Data, suggesting options traders expected movement.

Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Biogen (NASDAQ: BIIB) announced on 10/12/07 that its board of directors authorized management to evaluate whether third parties would have an interest in acquiring the company at a price and on terms that would represent a better value for stockholders. BIIB is recently up $3.06 to $77.05. BIIB December 90 calls are bid 50 cents. BIIB December 75 straddle is priced at $7.20, above a level of $5.55 from two hours ago. BIIB January option implied volatility of 53 is above its 26-week average of 36 according to Track Data, suggesting options traders expect movement.

Volatility Index (VIX) up 0.36 to 21.03; FOMC lowers Fed Funds rate 25 basis points to 4.25%.

MOST NOTEWORTHY: Kenneth Cole, Tempur Pedic, Biogen Idec, Cubist Pharma and ShoreTel were today's noteworthy initiations:

• B. Riley started shares of Kenneth Cole (NYSE: KCP) with a Neutral rating and $21 target, citing a lack of near-term catalysts and the challenging environment for footwear companies.
  
• William Blair resumed coverage of Tempur Pedic International (NYSE: TPX) with an Outperform rating, and finds the current valuation attractive for long-term investors.
  
• Banc of America assumed coverage of Biogen Idec (NASDAQ: BIIB) with a Neutral rating and $79 target, as they see less than 50% probability of a sale at current prices and expect shares to trade back to pre-announcement levels in the mid-to-high $60s if no sale is made.
  
• Cubist Pharmaceuticals (NASDAQ: CBST) was initiated with a Sector Performer rating at CIBC, citing competitive headwinds.
  
• ShoreTel (NASDAQ: SHOR) was initiated with a Neutral rating at Nollenberger on valuation.

OTHER INITIATIONS:

• UBS initiated CVS Caremark (NYSE: CVS) with a Buy rating and Rite Aid (RAD) and Walgreen (WAG) with Neutral ratings.
  
• Caris initiated Starent Networks (NASDAQ: STAR) with an Average rating and $23 target.